Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T00:01:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.2%
    Check dated 2025-01-12T18:59:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has updated to version v2.13.3, adding 'Results Submitted' while removing 'No Results Posted' from the previous version v2.13.2.
    Difference
    0.1%
    Check dated 2024-12-14T22:57:01.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T16:41:52.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The website has added a 'Show less' feature, while several detailed data fields and options related to study downloads have been removed.
    Difference
    3%
    Check dated 2024-11-23T05:07:52.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    Several key health-related links have been removed, including resources from MedlinePlus, DailyMed, and various government health websites.
    Difference
    0.3%
    Check dated 2024-11-16T00:25:26.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.